|
Market Closed -
CBOE
09:00:00 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 3.217 EUR | 0.00% |
|
0.00% | -40.37% |
| 09/09 | Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment | MT |
| 09/09 | Evotec Commences Early-stage Study of Potential Orthopoxvirus Therapy | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 4.55TCr | AAA | ||||||||
| 4.37TCr | - | B | - | - | |||||
| 4.31TCr | AAA | ||||||||
| 3.94TCr | - | ||||||||
| 3.19TCr | A | ||||||||
| 1.73TCr | - | - | - | - | |||||
| 1.64TCr | BBB | ||||||||
| 1.42TCr | AA | ||||||||
| 1.33TCr | AA | ||||||||
| 1.31TCr | AAA | ||||||||
| 1.13TCr | AA | ||||||||
| 1.06TCr | A | - | |||||||
| 1.02TCr | - | BBB | - | - | |||||
| 1.01TCr | AA | ||||||||
| 958.85Cr | BB | - | |||||||
| 955.9Cr | - | BBB | - | - | |||||
| 934.15Cr | - | B | - | - | |||||
| 902.31Cr | AA | - | |||||||
| 900.89Cr | - | A | - | - | |||||
| Average | 1.93TCr | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Stocks
- EVT Stock
- 0IRF Stock
- Sector Evotec SE
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
















